ArticleEuropean heart journal. Case reports2025
Intermediate coronary microvascular dysfunction: a case report highlighting challenges in diagnosis and management.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary microvascular dysfunction (CMD) is a heterogeneous and underappreciated clinical presentation of cardiac chest pain in the absence of obstructive epicardial coronary disease. While risk factors for CMD are not dissimilar from those that contribute to epicardial coronary disease (e.g. hypertension, diabetes, obesity, smoking, etc.), CMD requires additional therapy beyond addressing those risk factors. Case summary: A 46-year-old woman presented with cardiac chest pain and non-ST elevation myocardial infarction. Myocardial perfusion imaging demonstrated a large, moderate perfusion defect in the anterior myocardium. Left heart catheterization ruled out epicardial disease, and microvascular testing was intermediate. Nevertheless, her symptoms resolved completely with empiric medical management of presumed CMD. Discussion: Invasive ischaemic testing can facilitate a CMD diagnosis and offers more diagnostic specificity than non-invasive modalities. However, diagnostic thresholds remain debated and can be confounded by coronary anatomy and clinical profiles, posing challenges to accurately diagnosing CMD. A high index of suspicion and a low threshold for empiric treatment may be beneficial in alleviating symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.